OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
1.900
-0.100 (-5.00%)
At close: May 9, 2025, 4:00 PM
1.920
+0.020 (1.05%)
After-hours: May 9, 2025, 4:05 PM EDT
OnKure Therapeutics Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for OnKure Therapeutics stock ranges from a low of $30 to a high of $34. The average price target of $32.25 forecasts a 1,597.37% increase in the stock price over the next year.
Price Target: $32.25 (+1,597.37%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 18, 2025.
Analyst Ratings
The average analyst rating for OnKure Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $34 | Strong Buy | Maintains | $40 → $34 | +1,689.47% | Mar 18, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $35 → $30 | Buy | Maintains | $35 → $30 | +1,478.95% | Mar 11, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +1,584.21% | Jan 28, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $33 | Buy | Initiates | $33 | +1,636.84% | Dec 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +2,005.26% | Nov 8, 2024 |
Financial Forecast
Revenue This Year
n/a
from 680.00K
Revenue Next Year
n/a
EPS This Year
-5.29
from -15.28
EPS Next Year
-3.46
from -5.29
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.1M | 2.1M | 2.1M |
| Avg | 510,000 | 680,003 | 680,003 |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 208.8% | 311.8% | 208.8% |
| Avg | -25.0% | 33.3% | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -5.31 | -3.10 | -2.80 |
| Avg | -5.29 | -3.46 | -2.83 |
| Low | -5.23 | -3.76 | -2.82 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.